Table 1.

Demographic and clinical measures for treatment groups.

Demographics	CBTv group (n = 13; 7 males)		TAU group (n = 10; 6 males)
	Mean ± SD Baseline	Mean ± SD Follow-up	Mean ± SD Baseline	Mean ± SD Follow-up
Age (years)	41.77 ± 14.69		47.8 ± 11.81
Education (years)	4.62 ± 1.33		5.5 ± 1.18
Duration of illness (years)	16.1 ± 11.64		21.78 ± 9.60
PSYRATS total	25.15 ± 5.38	22.53 ± 6.21	27.5 ± 4.62	27.89 ± 4.76
PANSS
Positive Scale	15.62 ± 3.31	16.2 ± 4.41	15.6 ± 3.53	16.17 ± 5.94
Negative Scale	15.77 ± 4.78	16.2 ± 4.59	15.5 ± 4.17	13.7 ± 5.28
General	33.31 ± 13.71	30.3 ± 6.17	31.3 ± 6.43	31.67 ± 7.71

PSYRATS, The Auditory Hallucinations subscale from the Psychotic Symptom Rating Scale; PANSS, Positive and Negative Syndrome Scale.

Follow-up for the PANSS measures included missing data (3 missing cases from the CBTv group and 4 missing cases from the TAU only group).